169 related articles for article (PubMed ID: 3190183)
1. Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base.
Villa P; Sassella D; Corada M; Bartosek I
Antimicrob Agents Chemother; 1988 Oct; 32(10):1541-6. PubMed ID: 3190183
[TBL] [Abstract][Full Text] [Related]
2. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.
Carlier MB; Zenebergh A; Tulkens PM
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():47-56. PubMed ID: 3429386
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of macrolides.
Nilsen OG
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():81-8. PubMed ID: 3323170
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Viluksela M; Vainio PJ; Tuominen RK
J Antimicrob Chemother; 1996 Sep; 38(3):465-73. PubMed ID: 8889721
[TBL] [Abstract][Full Text] [Related]
5. Effects of roxithromycin, a new semisynthetic macrolide, and two erythromycins on drug metabolizing enzymes in rat liver.
Villa P; Sassella D; Corada M; Bartosek I
J Antibiot (Tokyo); 1988 Apr; 41(4):563-9. PubMed ID: 3372362
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems.
Dujovne CA; Salhab AS
Pharmacology; 1980; 20(6):285-91. PubMed ID: 7403251
[TBL] [Abstract][Full Text] [Related]
7. Erythromycin toxicity in primary cultures of rat hepatocytes.
Villa P; Bégué JM; Guillouzo A
Xenobiotica; 1985; 15(8-9):767-73. PubMed ID: 4072263
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin estolate-induced toxicity in cultured rat hepatocytes.
Sorensen EM; Acosta D
Toxicol Lett; 1985 Sep; 27(1-3):73-82. PubMed ID: 4060187
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
10. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat.
al-Humayyd MS
Chemotherapy; 1997; 43(2):77-85. PubMed ID: 9084915
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of roxithromycin: a laboratory evaluation.
Chantot JF; Bryskier A; Gasc JC
J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
Delaforge M; Sartori E; Mansuy D
Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
[TBL] [Abstract][Full Text] [Related]
14. Investigating the barriers to bioavailability of macrolide antibiotics in the rat.
Padovan J; Ralić J; Letfus V; Milić A; Bencetić Mihaljević V
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):163-71. PubMed ID: 22113743
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450.
Amacher DE; Schomaker SJ; Retsema JA
Antimicrob Agents Chemother; 1991 Jun; 35(6):1186-90. PubMed ID: 1656856
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 1. Uptake of 3H-macrolides by human macrophages.
Cuffini AM; Tullio V; Cimino F; Carlone NA
Microbios; 1989; 57(232-233):167-78. PubMed ID: 2739585
[TBL] [Abstract][Full Text] [Related]
17. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
18. An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin.
Anderson R; Van Rensburg CE; Jooné G; Lukey PT
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():57-68. PubMed ID: 3429387
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes.
Sorensen EM; Acosta D
Drug Chem Toxicol; 1985; 8(4):219-37. PubMed ID: 4075997
[TBL] [Abstract][Full Text] [Related]
20. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
